First-in-human phase I trial of the dual mTORC1 and mTORC2 inhibitor AZD2014 in solid tumors.
暂无分享,去创建一个
M. Ranson | U. Banerji | E. Harrington | S. Green | L. Grinsted | E. Oelmann | M. Krebs | A. Greystoke | W. Burke | E. Dean | B. Basu | Michael A. Gonzalez | M. Puglisi | Michael Gonzalez